Quarterly report · Q2
7129.TEDINET S100S68R
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥22.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥25m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥7m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥20m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥169m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥11m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥40m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥54m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥33m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥210m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥44m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥33m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥44m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥13.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥13.6bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.2bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥10.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥810m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥676m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥144m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥557m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥103m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥621m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥369m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥446m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-13.06 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.8 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.83 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.09 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥83.84 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 24.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.9% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥452m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥431m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥22m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥383m |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥243m |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥86m |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥245m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥10.6bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥10.6bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥402m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥408m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥443m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥430m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥17m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥13m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥13m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥393m |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥240m |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥61m |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E36714-000Nurturing Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥204m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥10.5bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.5bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥383m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥400m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 549
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 16789000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 400023000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -392608000 | JPY |
| Operating income | Prior1YTDDuration | 7414000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E36714-000MedicineReportableSegmentMember | 4547562000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E36714-000NursingCareBusinessReportableSegmentMember | 1605095000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E36714-000NurturingBusinessReportableSegmentMember | 4410668000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 10563326000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 430503000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 10993830000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 10993830000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E36714-000MedicineReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E36714-000NursingCareBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E36714-000NurturingBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 21731000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 21731000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -21731000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E36714-000MedicineReportableSegmentMember | 4547562000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E36714-000NursingCareBusinessReportableSegmentMember | 1605095000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E36714-000NurturingBusinessReportableSegmentMember | 4410668000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 10563326000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 452234000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 11015561000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -21731000 | JPY |
| Net sales | CurrentYTDDuration | 10993830000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E36714-000MedicineReportableSegmentMember | 243145000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E36714-000NursingCareBusinessReportableSegmentMember | -85719000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E36714-000NurturingBusinessReportableSegmentMember | 244634000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 402059000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 5949000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 408009000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -383058000 | JPY |
| Operating income | CurrentYTDDuration | 24950000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-11-09 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第３期第２四半期(自 2023年７月１日 至 2023年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ミアヘルサホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | Miahelsa Holdings Corporation | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 青木 文恵 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都新宿区市谷仲之町３番19号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-3341-7205（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)財務・企画担当取締役 高橋 雅彦 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都新宿区市谷仲之町３番19号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-3341-7205（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)財務・企画担当取締役 高橋 雅彦 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |